Summary
Definition
History and exam
Other diagnostic factors
- history of recurrent faints
- absence of structural heart disease
- provocative factor
- nausea
- low risk for adverse outcomes
- lightheadedness
- pallor
- diaphoresis
- diminished vision or hearing
- physical injury
- fatigue after episode
- palpitations
- bradycardia
- absence of family history of sudden death
- neuralgia
Risk factors
- prior syncope
- prior history of arrhythmias, myocardial infarction, heart failure, or cardiomyopathy
- severe aortic stenosis
- prolonged standing
- emotional stress (especially in a warm, crowded environment)
- dehydration/hypovolaemia
- preceding episode of nausea and/or vomiting
- preceding episode of severe pain
Diagnostic investigations
1st investigations to order
- 12-lead ECG
- serum haemoglobin
- plasma blood glucose
- serum beta-hCG (human chorionic gonadotrophin)
- cardiac enzymes
- D-dimer level
- serum cortisol
- urea or serum creatinine
Investigations to consider
- echocardiogram
- tilt-table test
- carotid sinus massage (CSM)
- insertable loop recorder
- electrophysiological study
- Valsalva manoeuvre
- active standing test
- cold pressor test
- cough test
Emerging tests
- adenosine triphosphate (ATP) test
Treatment algorithm
vasovagal faint
situational faint
carotid sinus syndrome
Contributors
Authors
Bryant Lin, MD

Clinical Assistant Professor of Medicine
Division of Primary Care and Population Health
Stanford University School of Medicine
Stanford
CA
Disclosures
BL declares that he has no competing interests.
Paul J. Wang, MD, FACC, FHRS

Professor of Medicine
Stanford Arrhythmia Service
Stanford University School of Medicine
Stanford
CA
Disclosures
PJW receives fellowship support, honoraria, and clinical trial support from Medtronic, which manufactures LINQ, an implantable loop recorder.
Acknowledgements
Dr Bryant Lin and Dr Paul J. Wang would like to gratefully acknowledge Dr David G. Benditt and Dr John T. Nguyen, previous contributors to this topic.
Disclosures
DGB has consultant and equity positions: Medtronic Inc., St Jude Medical Inc., Transoma Inc., Cardionet Inc. DGB is also an author of several references cited in this topic. JTN declares that he has no competing interests.
Peer reviewers
Sanjiv Petkar, MBBS, MD, DM (Cardiology), MRCP
Consultant Cardiologist
Hull and East Riding of Yorkshire NHS Trust
Castle Hill Hospital
East Yorkshire
UK
Disclosures
SP has received sponsorship in the past from Medtronic, Inc. and St Jude Medical, Inc. for attending conferences. He has received speaker's fees from Medtronic, Inc. In addition, he was in receipt of a research grant from Medtronic, Inc. to the University of Manchester.
Kenneth A. Ellenbogen, MD
Kontos Professor of Cardiology
Medical College of Virginia
Richmond
VA
Disclosures
KAE declares that he has no competing interests.
Andrew Parfitt, MBBS, FFAEM
Clinical Director
Acute Medicine
Associate Medical Director
Consultant Emergency Medicine
Guy's and St Thomas' NHS Foundation Trust
Clinical Lead and Consultant
Accident Emergency Medicine
St Thomas' Hospital
London
UK
Disclosures
AP declares that he has no competing interests.
References
Key articles
Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines, and the Heart Rhythm Society. Heart Rhythm. 2017 Aug;14(8):e155-217.Full text Abstract
Brignole M, Moya A, de Lange FJ, et al; ESC Scientific Document Group. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018 Jun 1;39(21):1883-948.Full text Abstract
Moya A, Brignole M, Menozzi C, et al; International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001 Sep 11;104(11):1261-7.Full text Abstract
Sandhu RK, Raj SR, Manlucu J, et al; Primary Writing Committee. Canadian Cardiovascular Society clinical practice update on the assessment and management of syncope. Can J Cardiol. 2020 Aug;36(8):1167-77.Full text Abstract
Reed MJ, Newby DE, Coull AJ, et al. The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol. 2010 Feb 23;55(8):713-21.Full text Abstract
Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol. 1996 Jul;28(1):263-75. Abstract
Raviele A, Giada F, Menozzi C, et al; Vasovagal Syncope and Pacing Trial Investigators. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The Vasovagal Syncope and Pacing Trial (SYNPACE). Eur Heart J. 2004 Oct;25(19):1741-8.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Orthostatic syncope (postural or orthostatic intolerance syncope syndromes)
- Bradycardia
- Bradycardia: AV conduction disorders
More DifferentialsGuidelines
- Transient loss of consciousness ('blackouts') in over 16s
- Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness
More GuidelinesPatient information
Atrial fibrillation: what is it?
Atrial fibrillation: what treatments work?
More Patient informationCalculators
San Francisco Syncope Rule TreeCalc
ROSE score: risk stratification of syncope in the emergency department
More CalculatorsLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer